Product Owner, SAP Finance Systems
Cellares - South San Francisco, California, us, 94083
Work at Cellares
Overview
- View job
Overview
We are seeking an experienced Sap Finance Systems Product Owner to support and enhance Sap-based finance processes in a Gmp-regulated biotech/life sciences environment. The primary focus of this position will be designing and optimizing Sap Finance, Controlling processes and Project systems modules to support compliant, efficient, and scalable finance processes. This is a multidisciplinary role & this individual will further interface across many parts of the company. The successful candidate will be the resident expert in the areas of Sap solutions. This is a hands-on position. Candidates should enjoy working in a fast-paced, mission-driven environment, and be prepared to tackle a broad selection of challenges as the company grows. Responsibilities
Configure and support Sap Fico (Gl, Ar, Ap, Aa, Ps, Co-cca, Co-pca, Copa, etc.) and Project Systems (Enable project-based cost tracking, Wbs structures, and capital planning) for Gmp and R&d initiatives Design and implement finance processes in Sap aligned with Gmp and Gxp standards Ensure Sap Ps integration with Fico and fixed asset management modules for end-to-end visibility and financial compliance Support compliance and audit readiness in alignment with Sox, Gxp, and Fda financial regulations Collaborate with adjacent functions including Ewm, Ptp, and Pharma Labeling to ensure accurate financial integration Contribute to a Clean Core approach by minimizing customizations and leveraging Sap Btp for extensibility Participate in fit-gap analysis, blueprint workshops, solution design, and stakeholder approvals Support monthly/quarterly close, internal controls, intercompany processes, and asset accounting Create and maintain documentation including functional specs, Sops, test scripts, and training materials Provide ongoing support, training, and change management for users Support process harmonization and compliant financial practices across global and local reporting structures Requirements
5+ years of hands-on experience in Sap Fico and Project Systems including S/4hana 2+ full lifecycle implementations in Sap Fico with strong Us localization knowledge Prior experience in a life sciences, pharma, or biotech environment Demonstrated understanding of Us Gaap, tax processing, and cost center structures specific to regulated industries Experience working in cross-regional models involving offshore teams Solid grasp of Clean Core principles, and exposure to Fiori-based solutions Exceptional communication, documentation, and client-facing skills Must be based in or willing to relocate to the San Francisco Bay Area Experience implementing Sap Fico solutions in biotech or advanced therapy environments Strong ability to translate financial compliance (Sox, Gxp) into scalable system configurations and controls Knowledge of clinical trial accounting, transfer pricing, and intercompany billing Exposure to Sap Central Finance, Sap Group Reporting, or Sap Btp extensions Experience working with labeling and supply chain integration in a pharma setting Cpa or Mba in Finance is a plus Self-awareness, integrity, authenticity, and a growth/entrepreneurial mindset $90,000 - $210,000 a year Cellares total compensation package contains competitive salaries, highly subsidized Medical, Dental, and Vision Plans, 401(k) Matching, Free EV Charging, and Onsite lunches. All displayed pay ranges are approximate, negotiable, and location dependent. This is Cellares Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.